A Blood Collection Study to Assess the Immunogenicity of Nationally Authorized Homologous COVID-19 Booster Vaccines Among Adult Vaccinees.
Condition(s):COVID-19Last Updated:July 27, 2023Withdrawn
Hide Studies Not Open or Pending
Condition(s):COVID-19Last Updated:July 27, 2023Withdrawn
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:February 9, 2021Unknown status
Condition(s):Cognitive Function and Mood; Cerebral Blood Flow; Systemic Inflammation; Gut Microbiota; Overweight and ObesityLast Updated:March 17, 2020Completed
Condition(s):Chronic MigraineLast Updated:February 12, 2013Completed
Condition(s):Influenza ALast Updated:March 2, 2011Completed
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:November 8, 2019Unknown status
Condition(s):Autoimmune Diseases; Epilepsy; Autonomic Dysfunction; Inflammatory Bowel DiseasesLast Updated:August 7, 2023Recruiting
Condition(s):Healthy; Bone; InflammationLast Updated:December 18, 2023Recruiting
Condition(s):Liver Cirrhosis; Portal HypertensionLast Updated:July 28, 2015Unknown status
Condition(s):Post Traumatic Stress DisorderLast Updated:February 15, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.